Mission BioCapital
Overview
Mission BioCapital is a venture capital firm founded in 2009, focused on making pivotal early-stage investments in life sciences companies. The firm invests in therapeutics, diagnostics, medical devices, and drug delivery. It supports its portfolio companies through a unique model that combines capital investment with shared lab space and access to strategic partners via partnerships with incubators like MBC BioLabs and LabCentral. The firm has offices in Cambridge, MA, and San Francisco, CA.
Portfolio Companies
48
Website
missionbiocapital.comInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Deck Bio | Apr 2026 | Seed | Co-investor |
| Beech Biotech SA | Apr 2026 | Pre Seed | Lead |
| EpiBiologics | Jan 2026 | Series B | Co-investor |
| Enodia Therapeutics | Jan 2026 | Seed | Co-investor |
| Nocion Therapeutics | Jan 2026 | Series B Extension | Co-investor |
Key People
Johannes Fruehauf
General Partner, Co-Founder
Peter Parker
Managing General Partner
Steve Tregay
Managing General Partner
Ulrik B. Nielsen
General Partner
Michael D Taylor
Operating Partner
Robert Blazej
Partner
Zach Collins
Partner
Cassidy Blundell
Principal
Chaya Patel
Principal
Clay Rowland
Investor
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
